The cause of colorectal cancer

Digestive and Liver Disease

Volumn 32, Issue 5, 2000, Pages 426-439

  Ponz de Leon, M ^a   Roncucci, L ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Adenoma; Cancer; Colon; FAP; HNPCC; Microsatellite instability; Polyp

Indexed keywords

ALCOHOL; SATURATED FATTY ACID;

ADENOMATOUS POLYP; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; DEVELOPED COUNTRY; DIETARY FIBER; ENTERITIS; ENVIRONMENTAL FACTOR; EXERCISE; FAMILIAL POLYPOSIS; FEMALE; FRUIT; GENE INACTIVATION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INDIA; MALE; MEAT; MICROSATELLITE INSTABILITY; MOLECULAR BIOLOGY; MORBIDITY; OBESITY; ONCOGENE; PHYSICAL ACTIVITY; REVIEW; SENEGAL; SMOKING; TUMOR SUPPRESSOR GENE; VEGETABLE; WESTERN HEMISPHERE;

EID: 0033855296     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(00)80265-0     Document Type: Review

References (156)

1. Genetic basis of tumour development
2. An update of HNPCC (Lynch syndrome)
3. Hereditary cancer
4. Overview of the epidemiology of colorectal cancer
5. Population-based surveillance by colonoscopy: Effect on the incidence of colorectal cancer
6. Advances in molecular genetics
7. K-ras codon 12 mutation determines the polypoid growth of colorectal cancer
8. Causes, relevant mechanisms, and prevention of large bowel cancer
9. Cancer incidence in the Greater Bombay, by religion and sex, 1973-1978
10. Comparison of colon-cancer survival among European countries: The Eurocare study
11. Patterns of gastrointestinal cancer in European migrants to Australia: The role of dietary change
12. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990
13. Colorectal cancer in Denmark 1943-1988
14. A marked increase in the incidence of colorectal cancer over two decades in Southwest Findland
15. Epidemiology of cancer of the large bowel - The 12-year experience of a specialized Registry in Northern Italy
16. Epidemiological evidence for distinguishing subsites of colorectal cancer
17. Trends in right and left-sided colon cancer
18. Colorectal cancer: Molecules and populations
19. Etiology of colorectal cancer with emphasis on mechanisms of action and prevention
20. Hereditary and familial colorectal cancer
21. Color cancer: A review of the epidemiology
22. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group
23. Effect of added calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer
24. Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas
25. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas
26. A clinical trial of antioxidant vitamins to prevent colorectal adenoma
27. Alcohol, low-methionine-low-folate diets and risk of colon cancer in men
28. Are dietary factors involved in DNA methylation associated with colon cancer?
29. Physical activity and risk of colorectal cancer in men and women
30. Physical activity and risk of cancers of the colon rectum: An Italian case-control study
31. Dietary risk factors for colon cancer in a low-risk population
32. Epidemiology of colorectal cancer revisited: Serum triglycerides and/or plasma glucose associated with risk?
33. Increased blood glucose and insulin, body size, and incident colorectal cancer
34. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells
35. Elevated serum gastrin levels in patients with colorectal neoplasia
36. Serum gastrin is not higher in subjects with colonic neoplasia
37. Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome
38. Gastrin and colorectal cancer: A prospective study
39. Cancer mortality among nuns: Role of marital status in etiology of neoplastic disease in women
40. Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis
41. Tobacco, alcohol, coffee, and caffeine as risk factors for colon cancer in a low-risk population
42. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women
43. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men
44. Tobacco use and colon cancer
45. Cancer incidence in North Wales and Liverpool region in relation to habits and environment
46. Incidence of colorectal cancer in proctocolitis: A retrospective study of 959 cases over 40 years
47. Cancer in patients with ulcerative colitis
48. Ulcerative colitis and colorectal cancer: A population study
49. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
50. Hypermethylation of the p16(INK4a) promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis
51. P53 and β catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas. An immunohistochemical study
52. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis
53. The risk of cancer in Crohn's disease
54. Increased risk of large bowel cancer in Crohn's disease with colonic involvement
55. Epidemiology of tumours of the colon and rectum: Incidence, mortality, survival and familiarity in the Health Care District of Modena, 1984-1992
56. The evolution of cancer of the colon and rectum
57. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors
58. Nonsteroidal antinflammatory drug use and reduced risk of large bowel carcinoma
59. Aspirin use and reduced fatal colon cancer
60. Tissue prostaglandin levels in familial adenomatous polyposis patients treated with Sulindac
61. Effect of Sulindac on sporadic colonic polyps
62. Ademocarcinoma in the rectal segment in familial polyposis coli is not prevented by Sulindac therapy
63. Incidence and familial occurence of colorectal cancer and polyps in a Health-Care district of Northern Italy
64. Early invasive carcinoma in colonic polyps
65. Familial juvennile polyposis. Study of a kindred: Evolution of polyps and relationship to gastrointestinal carcinoma
66. Flat adenoma, flat carcinoma and de novo carcinoma of the colon
67. Early invasive cancer in adenomatous colonic polyps (″Malignant polyps″). Evaluation of the therapeutic options by decision analysis
68. Molecular genetics of polyposis and hereditary colorectal cancer
69. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas
70. Interference with the Adenoma-Carcinoma sequence
71. Natural history of untreated colonic polyps
72. A detailed analysis of the role of K-ras gene mutation in the progressionn of colorectal adenoma
73. K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma
74. Genetic alterations during colorectal-tumor development
75. Tritiated thymidine labeling distribution as a marker for hereditary predisposition to colon cancer
76. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel
77. Hypomethylation of DNA from benign and malignant human colon neoplasms
78. Allelotype of colorectal carcinomas
79. Prevalence of ras gene mutations in human colorectal cancers
80. Genetic alterations in the adenoma-cacinoma sequence
81. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers
82. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression
83. Hereditary cancer in adults
84. Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome)
85. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer syndrome: Meeting highlights and Bethesda guidelines
86. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a model
87. Lessons from Hereditary Colorectal Cancer
88. Upper gastrointestinal disease in patients with familial adenomatous polyposis
89. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry
90. Familial aggregation of colorectal cancer in the general population
91. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands
92. Family incidence of carcinoma of the colon and rectum in north-east Scotland
93. The APC variants I1307J and E1317Q are associated with colorectal tumors, but not always with a family history
94. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews
95. Excess risk of colon cancer associated with a polymorphism of the APC gene?
96. The I1307K polymorphism of the APC gene in colorectal cancer
97. Frequency and clinical features of multiple tumors of the large bowel in general population and in patients with hereditary colorectal carcinoma
98. Hereditary Nonpolyposis Colorectal Cancer: Review of clinical, molecular genetics, and counseling aspects
99. The International Collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC)
100. New clinical criteria for Hereditary Nonpolyposis Colorectal Cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC
101. Hereditary nonpolyposis celorectal cancer in a Navajo Indian family
102. Hereditary nonpolyposis colorectal cancer: An awareness
103. Dominant inheritance of adenomatous colonic polyps and colorectal cancer
104. Frequency of hereditary colorectal carcinoma
105. Frequency of hereditry nonpolyposis colorectal cancer in Southern Alberta
106. Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with ″suspected HNPCC″. A populaton-based study in Northern Italy
107. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
108. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer
109. Genetic mapping of a locus predisposing to human colorectal cancer
110. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients
111. Mutation of a mutL homolog in hereditary colon cancer
112. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Mutations predisposing to Hereditary Nonpolyposis Colorectal Cancer: Database and results of a collaborative study
113. Microsatellite instability: Marker of a mutator phenotype in cancer
114. Microsatellite instability, mismatch repair deficiency and genetic defects in human cancer cell lines
115. Replication errors in benign and malignant tumors from Hereditary Nonpolyposis Colorectal Cancer patients
116. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer
117. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismath repair protein MLH1
118. Charcaterizaton of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer
119. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer
120. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 eastern United States hereditary nonpolyposis colorectal cancer pedigrees
121. Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families
122. Gene tests and counseling for colorectal cancer risk: Lessons from familial polyposis
123. Identification and characterization of the familial adenomatous polyposis coli gene
124. Hereditary gastrointestinal polyposis syndromes
125. Management strategies for familial adenomatous polyposis
126. Surgery for the teenager with familial adenomatous polyposis: Ileo-rectal anastomosis or restorative proctolectomy?
127. Adenomatosis coli in Japan
128. Clinical and biologic features of adenomatosis coli in Northern Italy
129. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis
130. A genetic study of Gardner syndrome and congenital hypertrophy of the retinal pigment epithelium
131. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment
132. The enigma of desmoid tumors
133. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis?
134. Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene
135. A father and son with Turcot's syndrome: Evidence for autosomal dominant inheritance. Report of two cases
136. Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) gene
137. Novel germline APC variants in patients with multiple adenomas
138. Localization of the gene for familial adenomatous polyposis on chromosome 5
139. Identification of FAP locus gene from chromosome 5q12
140. The PAC tumor suppressor protein in development and cancer
141. Analysis of masked mutations in familial adenomatous polyposis
142. Identification of deletion mutations and three new genes at the familial polyposis locus
143. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene
144. Severe upper gastrointestinal polyposis associated with sparse colonic polyposis in a familial adenomatous polyposis family with an APC mutation at codon 1520
145. Clinical features and genotype-phenotype correlations in 41 Italian families with Adenomatosis coli
146. Phenotypic expression in familial adenomatous polyposis: Partial prediction by mutation analysis
147. APC gene mutations and extrainestinal phenotype of familial adenomatous polyposis
148. Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli
149. Different expressivity of two adjacent mutations of the APC gene
150. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of APC(Min)-induced intestinal neoplasia
151. Apc(Min): A mouse model for intestinal and mammary tumorigenesis
152. Host factors in carcinogenesis: Certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer
153. Mutagens-carcinogens in foods
154. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection